149 related articles for article (PubMed ID: 12056292)
1. [New and old therapeutic options in ankylosing spondylitis--is there an indication for sulfasalazine?].
Braun J; Sieper J
Z Rheumatol; 2002 Apr; 61(2):151-8. PubMed ID: 12056292
[No Abstract] [Full Text] [Related]
2. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
[TBL] [Abstract][Full Text] [Related]
3. [Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies].
Schmidt WA; Wierth S; Milleck D; Droste U; Gromnica-Ihle E
Z Rheumatol; 2002 Apr; 61(2):159-67. PubMed ID: 12056293
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication?
Ward MM
Arthritis Rheum; 2011 Jun; 63(6):1472-4. PubMed ID: 21630241
[No Abstract] [Full Text] [Related]
5. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis.
Khanna Sharma S; Kadiyala V; Naidu G; Dhir V
Int J Rheum Dis; 2018 Jan; 21(1):308-314. PubMed ID: 28737251
[TBL] [Abstract][Full Text] [Related]
6. Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia.
Damjanov N; Shehhi WA; Huang F; Kotak S; Burgos-Vargas R; Shirazy K; Bananis E; Szumski A; Llamado LJ; Mahgoub E
Rheumatol Int; 2016 May; 36(5):643-51. PubMed ID: 26968844
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
[TBL] [Abstract][Full Text] [Related]
8. [A very late onset ankylosing spondylitis].
Druesne L; Verdonck A; Derambure V; Kadri K; Chassagne P; Bercoff E; Doucet J
Rev Med Interne; 2003 May; 24(5):331-2. PubMed ID: 12763182
[No Abstract] [Full Text] [Related]
9. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
van der Horst-Bruinsma IE; Clegg DO; Dijkmans BA
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S67-70. PubMed ID: 12463451
[TBL] [Abstract][Full Text] [Related]
10. Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman.
Suh YS; Kim HO; Cheon YH; Jo W; Hong J; Lee SI
Korean J Intern Med; 2017 Mar; 32(2):374-377. PubMed ID: 26842104
[No Abstract] [Full Text] [Related]
11. A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
Chogle AR; Mishra H; Chakravarty A
J Assoc Physicians India; 2007 May; 55():380; author reply 380-1. PubMed ID: 17844703
[No Abstract] [Full Text] [Related]
12. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
Haibel H; Specker C
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
[TBL] [Abstract][Full Text] [Related]
13. [Disease-modifying anti-rheumatic drugs for treatment of ankylosing spondylitis].
Madsen OR; Egsmose C
Ugeskr Laeger; 2009 Aug; 171(33):2268-72. PubMed ID: 19732504
[TBL] [Abstract][Full Text] [Related]
14. Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.
Tsai WC; Chen CJ; Yen JH; Liu HW
Clin Rheumatol; 2002 Aug; 21(4):339-40. PubMed ID: 12296286
[No Abstract] [Full Text] [Related]
15. Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis: comment on the article by Paul et al.
Marino C; McDonald E
Arthritis Care Res; 2000 Oct; 13(5):335; author reply 335. PubMed ID: 14635305
[No Abstract] [Full Text] [Related]
16. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
Burgos-Vargas R; Vázquez-Mellado J; Pacheco-Tena C; Hernández-Garduño A; Goycochea-Robles MV
Ann Rheum Dis; 2002 Oct; 61(10):941-2. PubMed ID: 12228171
[No Abstract] [Full Text] [Related]
17. Sensorineural hearing loss in a patient with ankylosing spondylitis.
Corapci I; Armagan O; Tascioglu F; Oner C
Rheumatol Int; 2004 Jul; 24(4):252-3. PubMed ID: 14727055
[No Abstract] [Full Text] [Related]
18. New-onset psoriasis associated with etanercept therapy.
Chen LA; Su LH; Chang YJ; Hsu YL; Tsai TH
J Dermatol; 2010 Apr; 37(4):378-80. PubMed ID: 20507411
[No Abstract] [Full Text] [Related]
19. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
[TBL] [Abstract][Full Text] [Related]
20. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial.
Nissilä M; Lehtinen K; Leirisalo-Repo M; Luukkainen R; Mutru O; Yli-Kerttula U
Arthritis Rheum; 1988 Sep; 31(9):1111-6. PubMed ID: 2901839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
